The mutation is a three nucleotide (CTG) in-frame deletion in exon 16. This mutation is predicted to result in the deletion of a leucine residue in a highly conserved stretch of five leucines (amino acids 537541) of the encoded protein. In vitro studies showed that the mutant protein is unstable and is present at 1% of the control level. (J:251816)